Cancer is the second leading cause of death worldwide, disproportionately affecting Low-and-Middle-Income Countries(LMICs). In 2020, 70% of the nearly 10 million cancer-related deaths worldwide occurred in these regions. Limited healthcare resources and a shortage of specialized medical professionals in these countries make it challenging to provide high-quality, personalized cancer care.
Generative AI can revolutionize cancer care in these countries by providing real-time access to essential medications, offering personalized treatment plans, empowering healthcare professionals, and ultimately reducing mortality rates.